(Q84624126)

English

Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia?

scientific article published on July 31, 2010

In more languages
default values for all languages
No label defined

No description defined

Statements

Should minimal residual disease monitoring be the standard of care for all patients with acute promyelocytic leukemia? (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit